Medicament comprising PTX3, alone or in combination with TSG-6, for treating degenerative diseases of cartilage and bone and treating female infertility

Details for Australian Patent Application No. 2004305342 (hide)

Owner Defiante Farmaceutica LDA.

Inventors Garlanda, Cecilia; Botazzi, Barbara; Mantovani, Alberto; Carminati, Paolo

Agent Davies Collison Cave

Pub. Number AU-A-2004305342

PCT Pub. Number WO2005/060988

Priority RM2003A000595 23.12.03 IT

Filing date 21 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/060988 Priority application(s): WO2005/060988

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305345-High-frequency heating balloon catheter

2004305341-Medicament comprising inhibitors of long pentraxin PTX3